Navigation Links
Researchers advance biosynthesis of potent anti-cancer drug Taxol
Date:9/30/2010

MEDFORD/SOMERVILLE, Mass.--Researchers from Tufts University School of Engineering and MIT have reported a new way to biosynthesize important precursors to the potent anti-cancer compound Taxol in an engineered strain of E. coli bacteria.

The findings are significant steps on the way to achieving cost-effective, large-scale production of Taxol and the effort to design new Taxol-like pharmaceuticals.

The work is reported in the October 1, 2010, issue of the journal Science.

Taxol (paclitaxel) and its structural analogs are among the most powerful and commercially successful anticancer drugs, used to treat Kaposi's sarcoma and breast, lung and ovarian tumors.

Taxol was originally derived from the bark of the Pacific yew tree. Its anti-cancer properties were discovered more than 40 years ago.

But Taxol's power comes with an environmental price: Early stage production methods required sacrificing two to four fully grown trees for each patient. Alternative means of production such as using needles rather than bark still rely on slow, laborious plant-based processes. This limits production of Taxol itself and development of new derivatives that might be even more effective.

"This was the basis for our efforts to redirect biosynthesis through a simple, process-friendly bacterium like E. coli," explains Tufts' Blaine Pfeifer, Ph.D., assistant professor of chemical and biological engineering and co-corresponding author on the paper. "We faced a tremendous challenge because of the engineering needed first to 'equip' the E. coli cell to support Taxol biosynthesis and the subsequent protein engineering required to allow the first two steps in the Taxol biosynthesis scheme to be active within this new host."

The complex metabolic sequence that produces Taxol involves at least 17 intermediate steps and is not fully understood. The team's goal was to optimize production of the first two Taxol int
'/>"/>

Contact: Kim Thurler
kim.thurler@tufts.edu
617-627-3175
Tufts University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... As interest in the value of spiritual ... worldwide, Rev. Eric J. Hall , president and CEO ... will be the keynote speaker on January 27 at an ... system. , The conference, “Hope and Resilience: Innovative and Interdisciplinary ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
(Date:1/22/2015)... Step into a macabre world where plants ... Virginia. Wicked Plants, the Museum’s latest featured exhibition, opens ... carnivorous and diabolical plants inside of a dilapidated, Victorian ... biochemical, physical and neurological processes between botanicals and the ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 The US represents ... this report. In 2013, GlobalData’s forecast estimates that sales of ... CRC market due to the high incidence of the disease, ... the 5EU, Japan, and China. Increased sales of CRC therapies ...
(Date:12/26/2014)... December 26, 2014 Cooking and warming ... of 5. This score reflects slightly positive negotiation conditions for ... switching costs and a low level of price volatility. “However, ... for cooking and warming equipment and high volatility in the ...
Breaking Medicine News(10 mins):Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3
... pain, the two competing schools of thought are that it,s ... A new study led by University of Oxford researchers indicates ... Depression and pain often co-occur, but the underlying mechanistic ... interaction between depression and pain, Dr. Chantal Berna and colleagues ...
... for a parent recovering from stroke are more prone ... Canadian Stroke Congress, co-hosted by the Canadian Stroke Network, ... Consortium. Caring for a parent who has experienced ... usual parent-child relationship. "Stroke can be particularly challenging ...
... incident parasomnias are uncommon as children enter adolescence, parasomnias ... according to a research abstract that will be presented ... SLEEP 2010, the 24th annual meeting of the Associated ... rate of persistence after five years was 29 percent ...
... ... the 26th of June 2010. The funds will go to the charities of Live and Cudeca. ... (PRWEB) June 5, 2010 -- On ... with the 4B business networking group a charity skydiving event in Seville. , , ,The collected ...
... myeloid leukemia patients responded to Sprycel and Tasigna than ... new drugs, dasatinib (Sprycel) and nilotinib (Tasigna), appear better ... chronic myeloid leukemia and should be considered as first-line ... should change clinical practice, are to be presented Saturday ...
... - Dasatanib, a medication currently approved as treatment for ... better responses as a first therapy than the existing ... Texas MD Anderson Cancer Center. The findings were ... Society of Clinical Oncology today, and published in the ...
Cached Medicine News:Health News:Daughters caring for a parent recovering from stroke more prone to depression than sons 2Health News:Childhood parasomnias such as sleepwalking and bedwetting may persist into adolescence 2Health News:Newer Drugs Beat Gleevec in Head-to-Head Trials 2Health News:Newer Drugs Beat Gleevec in Head-to-Head Trials 3Health News:Newer Drugs Beat Gleevec in Head-to-Head Trials 4Health News:Second-line CML drug evokes faster response, fewer side effects, pivotal study finds 2
(Date:1/23/2015)... Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself ... share and grab a foothold in the hydroponic, hemp and ... and a presence in the sector, and recently partnering with ... of hemp and medical marijuana, iMD is committing to bring ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
(Date:1/23/2015)... , Jan. 23, 2015 Tianyin Pharmaceutical Inc. (NYSE ... specializes in the development and sale of patented biopharmaceutical ... active pharmaceutical ingredients (API) today announced the business and ... operation. 1. Following the September 2014 JCM ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... UBM Live , a division of UBM Plc ... 2011 and co-located events ICSE China for contract and outsourced ... China to cater to the biopharmaceuticals market, held from June ... 36% increase in attendance from the 2010 events. Over three ...
... CHICAGO, July 12, 2011 Millennium Pharmacy Systems, the ... nursing and assisted living care settings, has announced a ... MPSRx®. With improved speed and usability as a motive, ... module (electronic medication order entry). Enhancements to the ...
Cached Medicine Technology:China Pharma Events Attract Over 27,000 Visitors 2China Pharma Events Attract Over 27,000 Visitors 3Now Faster & Easier — Millennium Pharmacy Systems Announces New Release of MPSRx® 2
... ,Designed for neonatal and pediatric patient ... monitoring lumen within the wall of the ... Luer lock connector bonded to lumen line ... monitoring or syringe irrigation of medication., ...
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes...
Nasal soft cuffed endotracheal tubes designed and constructed especially for long-term nasal intubations....
Pediatric Tracheal Tubes with Micro-thin-walled cuffs....
Medicine Products: